четверг, 14 ноября 2013 г.

New technology combining contraception, HIV and herpes simplex virus-2 prevention

CONRAD Head of drug delivery, Meredith Clark, PhD, presented preclinical data on a new intravaginal ring that provides contraception as well as HIV-1 and HSV-2 prevention at the 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in San Antonio, Texas.



Комментариев нет:

Отправить комментарий